SAN DIEGO – February 11, 2019 – Amplyx Pharmaceuticals, a
Read moreFDA Grants Orphan Drug Designation to Amplyx Pharmaceuticals for APX001 for Treatment of Cryptococcosis
FDA Approves Imbruvica (ibrutinib) Plus Obinutuzumab as First Non-Chemotherapy Combination Regimen for Treatment-Naïve Patients with Chronic Lymphocytic Leukemia
HORSHAM, Pa., Jan. 28, 2019 /PRNewswire/ — The Janssen Pharmaceutical
Read moreFDA Approves The ACTpen for Actemra, A Single-Dose, Prefilled Autoinjector
South San Francisco, CA — November 26, 2018 — Genentech,
Read moreFDA warns high levels of heavy metals found in kratom products
The U.S. Food and Drug Administration issued an advisory Tuesday
Read moreFDA Warns Against Giving Honey-Filled Pacifiers to Infants
MONDAY, Nov. 19, 2018 — Pacifiers filled with or dipped
Read moreFDA Approves Powerful New Opioid, Dsuvia (Sufentanil), Despite Criticisms
FRIDAY, Nov. 2, 2018 — Ruling against the recommendation of
Read moreFDA Too Quick to Call BPA Chemical Safe, Health Experts Say
TUESDAY, Oct. 23, 2018 — The U.S. Food and Drug
Read moreAxsome Therapeutics Receives FDA Orphan Drug Designation for AXS-12 for the Treatment of Narcolepsy
NEW YORK, Oct. 17, 2018 (GLOBE NEWSWIRE) — Axsome Therapeutics,
Read moreFDA Approves Yutiq
WATERTOWN, Mass., Oct. 15, 2018 (GLOBE NEWSWIRE) — EyePoint Pharmaceuticals,
Read moreFDA Approves Accelerated 7-Day Vaccine Dosing Schedule for Ixiaro
GAITHERSBURG, Md.–(BUSINESS WIRE) October 05, 2018 –Valneva USA, the U.S.
Read more